Frequent upregulation of MYC in plasma cell leukemia
- 24 April 2009
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 48 (7), 624-636
- https://doi.org/10.1002/gcc.20670
Abstract
Plasma cell leukemia (PCL) is a rare form of monoclonal gammopathy, which can originate de novo or evolve from multiple myeloma (MM) as a terminal leukemic phase. Previous cytogenetic studies of PCL have reported the presence of complex karyotypes with involvement of multiple unidentified chromosomal regions. We report here the analysis of 12 PCL (10 primary and two secondary) by metaphase and FISH analysis combined with oligonucleotide array data (244 k, Agilent). Interphase-FISH results were compared with those from a series of 861 newly diagnosed patients with MM. Cytogenetic analysis was successful on 11 patients, all of whom showed clonal chromosomal abnormalities. Compared with MM, t(11;14)(q13;q32) (42% versus 15%; P = 0.027) and t(14;16)(q32;q23) (25% versus 4%; P = 0.010) were more frequent in PCL, although neither the specific partner chromosome involved in the IgH translocation nor the ploidy status predicted for survival. Chromosomes 1, 8, 13, and 16 showed the highest number of copy number alterations with 8q24 being the chromosomal region most frequently involved. In eight of 12 patients we found abnormalities (translocations, one amplification, small deletions, and duplications) that directly targeted or were very close to MYC. Only four of these changes were detected by routine FISH analysis using commercial probes with the others exclusively detected by arrays. Quantitative reverse transcription polymerase chain reaction demonstrated that these different abnormalities were associated with increased levels of MYC mRNA. We conclude that MYC dysregulation by complex mechanisms is one of the major molecular events in the oncogenesis of PCL.Keywords
This publication has 47 references indexed in Scilit:
- Genomic complexity identifies patients with aggressive chronic lymphocytic leukemiaBlood, 2008
- Characterization of MYC Translocations in Multiple Myeloma Cell LinesJNCI Monographs, 2008
- Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumorsGenes, Chromosomes and Cancer, 2008
- The molecular classification of multiple myelomaBlood, 2006
- Fusion of the Tumor-Suppressor Gene CHEK2 and the Gene for the Regulatory Subunit B of Protein Phosphatase 2 PPP2R2A in Childhood TeratomaNeoplasia, 2006
- Complex rearrangements involving der(8)t(8;20) and der(14)t(8;14)t(11;14), CCND1, and duplication of IgH constant region in acute plasmablastic leukemiaCancer Genetics and Cytogenetics, 2006
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Primary plasma cell leukaemiaBritish Journal of Haematology, 1994
- Cell Surface Markers in Multiple MyelomaMayo Clinic Proceedings, 1994
- Karyotype in multiple myeloma and plasma cell leukaemiaEuropean Journal Of Cancer, 1993